Abstract:In recent years, significant advancements have been made in utilizing nanoparticles (NPs) to modulate immune responses within the central nervous system (CNS), offering new opportunities for nanotherapeutic interventions in neurological disorders. NPs can serve as carriers for immunomodulatory agents or platforms for delivering nucleic acid-based therapeutics to regulate gene expression and modulate immune responses. Several studies have demonstrated the efficacy of NP-mediated immune modulation in preclinical models of neurological diseases, including multiple sclerosis, stroke, Alzheimer's disease, and Parkinson's disease. While challenges remain, advancements in NPs engineering and design have led to the development of NPs using diverse strategies to overcome these challenges. The nano-bio interface with the immune system is key in the conceptualization of NPs to efficiently act as nanotherapeutics in the CNS. The biomolecular corona plays a pivotal role in dictating NPs behavior and immune recognition within the CNS, giving researchers the opportunity to optimize NPs design and surface modifications to minimize immunogenicity and enhance biocompatibility. Here, we review how NPs interact with the CNS immune system, focusing on immunosurveillance of NPs, NP-induced immune reprogramming and the impact of the biomolecular corona on NPs behavior in CNS immune responses. The integration of NPs into CNS nanotherapeutics offers promising opportunities for addressing the complex challenges of acute and chronic neurological conditions and pathologies, also in the context of preventive and rehabilitative medicine. By harnessing the nano-bio immune interface and understanding the significance of the biomolecular corona, researchers can develop targeted, safe, and effective nanotherapeutic interventions for a wide range of CNS disorders to improve treatment and rehabilitation. These advancements have the potential to revolutionize the treatment landscape of neurological diseases, offering promising solutions for improved patient care and quality of life in the future.

Nanoparticle‐Based Therapies for Neurotropic Viral Infections: Mechanisms, Challenges, and Future Prospects

Functionalized Nanoparticles in Prevention and Targeted Therapy of Viral Diseases With Neurotropism Properties, Special Insight on COVID-19

A Nanobody-Mediated Virus-Targeting Drug Delivery Platform for the Central Nervous System Viral Disease Therapy

Application of virus targeting nano-carrier drug delivery system in virus-induced central nervous system diseases treatment.

Potential Therapeutic Strategies to Halt Viral Neuroinvasion

Nanoparticle-based Gene Therapy for Neurodegenerative Disorders

Engineering advanced nanomedicines against central nervous system diseases

Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases

Nano-based approaches in the development of antiviral agents and vaccines

Viral Nanoparticles‐Mediated Delivery of Therapeutic Cargo

Nanotechnology-based antiviral therapeutics

Nanomedicine for the Treatment of Viral Diseases: Smaller Solution to Bigger Problems

Recent Advances in Nanotherapeutics for Neurological Disorders

Research Progress in Nanopharmaceuticals with Different Delivery Routes in the Antivirus Field.

Recent Updates on the Role of Nanoparticles in the Treatment of Viral Diseases

Trends in nano-platforms for the treatment of viral infectious diseases

Nanotechnology-driven therapies for neurodegenerative diseases: a comprehensive review

Navigating the nano-bio immune interface: advancements and challenges in CNS nanotherapeutics

Nanotechnology and the treatment of HIV infection

Research Progress of Brain-Targeted Nanoparticles Carrying Therapeutic Molecules

RVG Peptide-Functionalized Favipiravir Nanoparticle Delivery System Facilitates Antiviral Therapy of Neurotropic Virus Infection in a Mouse Model.